The use of nomograms in the detection of prostate cancer

被引：8

作者：

Roobol, M. J. ^{[1
]}

机构：

[1] Erasmus MC, Dept Urol, NL-3000 CA Rotterdam, Netherlands

来源：

PROSTATE | 2006年 / 66卷 / 12期

关键词：

D O I：

10.1002/pros.20454

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1266 / 1267

页数：2

共 10 条

[1] Prostate cancer screening in the prostate, lung, colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screening round of a randomized trial [J].

Andriole, GL ;

Levin, DL ;

Crawford, ED ;

Gelmann, ER ;

Pinsky, PF ;

Chia, D ;

Kramer, BS ;

Reding, D ;

Church, TR ;

Grubb, RL ;

Izmirlian, G ;

Ragard, LR ;

Clapp, JD ;

Prorok, PC ;

Gohagan, JK .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :433-438

[2] Novel artificial neural network for early detection of prostate cancer [J].

Djavan, B ;

Remzi, M ;

Zlotta, A ;

Seitz, C ;

Snow, P ;

Marberger, M .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :921-929

[3] Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels 10 ng/mL [J].

Garzotto, M ;

Hudson, RG ;

Peters, L ;

Hsieh, YC ;

Barrera, E ;

Mori, M ;

Beer, TM ;

Klein, T .

CANCER, 2003, 98 (07) :1417-1422

[4] Counseling men with prostate cancer: A nomogram for predicting the presence of small, moderately differentiated, confined tumors [J].

Kattan, MW ;

Eastham, JA ;

Wheeler, TM ;

Maru, N ;

Scardino, PT ;

Erbersdobler, A ;

Graefen, M ;

Huland, H ;

Koh, H ;

Shariat, SF ;

Slawin, KM ;

Ohori, M .

JOURNAL OF UROLOGY, 2003, 170 (05) :1792-1797

[5] Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium [J].

Partin, AW ;

Mangold, LA ;

Lamm, DM ;

Walsh, PC ;

Epstein, JI ;

Pearson, JD .

UROLOGY, 2001, 58 (06) :843-848

[6] Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial [J].

Pinsky, PF ;

Andriole, GL ;

Kramer, BS ;

Hayes, RB ;

Prorok, PC ;

Gohagan, JK .

JOURNAL OF UROLOGY, 2005, 173 (03) :746-750

[7] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].

Prorok, PC ;

Andriole, GL ;

Bresalier, RS ;

Buys, SS ;

Chia, D ;

Crawford, ED ;

Fogel, R ;

Gelmann, EP ;

Gilbert, F ;

Hasson, MA ;

Hayes, RB ;

Johnson, CC ;

Mandel, JS ;

Oberman, A ;

O'Brien, B ;

Oken, MM ;

Rafla, S ;

Reding, D ;

Rutt, W ;

Weissfeld, JL ;

Yokochi, L ;

Gohagan, JK .

CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :273S-309S

[8] A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (Results of ERSPC, Rotterdam) [J].

Roobol, MJ ;

Schröder, FH ;

Kranse, R .

PROSTATE, 2006, 66 (06) :604-612

[9]

Sackett D, 2000, EVIDENCE BASED MED P

[10] The story of the European Randomized study of screening for prostate cancer [J].

Schröder, FH ;

Denis, LJ ;

Roobol, M .

BJU INTERNATIONAL, 2003, 92 :1-13

← 1 →